Kathleen Victoria Fitch, M.S.N.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 81 | 2023 | 16202 | 3.290 |
Why?
|
Plaque, Atherosclerotic | 14 | 2023 | 1396 | 1.410 |
Why?
|
Coronary Artery Disease | 19 | 2023 | 6197 | 1.120 |
Why?
|
Cardiovascular Diseases | 21 | 2023 | 14701 | 1.050 |
Why?
|
HIV | 11 | 2023 | 1563 | 1.040 |
Why?
|
Sweetening Agents | 2 | 2022 | 286 | 0.900 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 10 | 2023 | 3172 | 0.890 |
Why?
|
Life Style | 5 | 2019 | 3780 | 0.740 |
Why?
|
Atherosclerosis | 8 | 2023 | 3267 | 0.680 |
Why?
|
Amino Acids | 3 | 2020 | 1724 | 0.670 |
Why?
|
Diet Therapy | 1 | 2019 | 153 | 0.670 |
Why?
|
Quinolines | 7 | 2023 | 725 | 0.650 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 5 | 2021 | 138 | 0.590 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1533 | 0.530 |
Why?
|
Renin-Angiotensin System | 6 | 2022 | 752 | 0.510 |
Why?
|
Monocytes | 4 | 2018 | 2571 | 0.510 |
Why?
|
Fibrosis | 2 | 2018 | 1990 | 0.460 |
Why?
|
Bone Diseases | 2 | 2019 | 415 | 0.450 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 5 | 2018 | 293 | 0.440 |
Why?
|
Adiposity | 7 | 2021 | 1785 | 0.430 |
Why?
|
Tunica Media | 2 | 2011 | 116 | 0.410 |
Why?
|
Inflammation | 14 | 2023 | 10335 | 0.410 |
Why?
|
Asymptomatic Diseases | 5 | 2018 | 549 | 0.390 |
Why?
|
Middle Aged | 71 | 2023 | 212292 | 0.390 |
Why?
|
Dyslipidemias | 3 | 2019 | 842 | 0.390 |
Why?
|
Nutrition Disorders | 1 | 2011 | 211 | 0.390 |
Why?
|
Patient Selection | 2 | 2020 | 4200 | 0.370 |
Why?
|
Subcutaneous Fat | 5 | 2019 | 388 | 0.370 |
Why?
|
Tunica Intima | 2 | 2011 | 475 | 0.350 |
Why?
|
Metformin | 2 | 2014 | 807 | 0.340 |
Why?
|
Intra-Abdominal Fat | 4 | 2019 | 586 | 0.340 |
Why?
|
Aging | 3 | 2020 | 8530 | 0.320 |
Why?
|
Arteritis | 2 | 2022 | 142 | 0.320 |
Why?
|
Fingers | 1 | 2011 | 510 | 0.320 |
Why?
|
Neck | 2 | 2016 | 686 | 0.310 |
Why?
|
Diet | 4 | 2022 | 7797 | 0.310 |
Why?
|
Adipose Tissue, Brown | 4 | 2019 | 764 | 0.300 |
Why?
|
Ribonuclease III | 2 | 2021 | 282 | 0.300 |
Why?
|
Anti-Retroviral Agents | 6 | 2023 | 1674 | 0.300 |
Why?
|
Carotid Arteries | 1 | 2011 | 945 | 0.290 |
Why?
|
Adipose Tissue | 5 | 2021 | 3264 | 0.280 |
Why?
|
Viral Nonstructural Proteins | 1 | 2018 | 245 | 0.280 |
Why?
|
Male | 68 | 2023 | 347096 | 0.280 |
Why?
|
DEAD-box RNA Helicases | 2 | 2021 | 378 | 0.280 |
Why?
|
Calcinosis | 2 | 2012 | 1466 | 0.270 |
Why?
|
Body Composition | 12 | 2019 | 2416 | 0.270 |
Why?
|
Drug Resistance, Viral | 2 | 2023 | 806 | 0.260 |
Why?
|
Humans | 92 | 2023 | 725187 | 0.260 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 9588 | 0.260 |
Why?
|
Female | 68 | 2023 | 375449 | 0.260 |
Why?
|
Anti-HIV Agents | 9 | 2020 | 4172 | 0.260 |
Why?
|
Adult | 47 | 2023 | 211615 | 0.260 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 1121 | 0.250 |
Why?
|
HIV Integrase Inhibitors | 2 | 2023 | 133 | 0.250 |
Why?
|
Receptors, Cell Surface | 5 | 2018 | 2877 | 0.250 |
Why?
|
Risk Factors | 21 | 2023 | 71009 | 0.240 |
Why?
|
Viral Load | 8 | 2022 | 3236 | 0.240 |
Why?
|
Exercise | 1 | 2019 | 5487 | 0.230 |
Why?
|
Nutritional Status | 1 | 2011 | 1578 | 0.230 |
Why?
|
Insulin Resistance | 6 | 2021 | 3871 | 0.230 |
Why?
|
Antigens, CD | 5 | 2018 | 4052 | 0.230 |
Why?
|
Sex Factors | 7 | 2019 | 10382 | 0.220 |
Why?
|
Body Mass Index | 10 | 2023 | 12523 | 0.220 |
Why?
|
HIV Integrase | 1 | 2023 | 118 | 0.210 |
Why?
|
Blood Proteins | 3 | 2023 | 1123 | 0.200 |
Why?
|
Subcutaneous Fat, Abdominal | 2 | 2019 | 92 | 0.190 |
Why?
|
Proteomics | 4 | 2023 | 3447 | 0.190 |
Why?
|
Hepacivirus | 1 | 2018 | 1349 | 0.190 |
Why?
|
Lipoproteins, LDL | 3 | 2022 | 628 | 0.190 |
Why?
|
HIV-1 | 6 | 2023 | 6849 | 0.190 |
Why?
|
HIV Long-Term Survivors | 1 | 2020 | 126 | 0.180 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 2769 | 0.180 |
Why?
|
Hyperinsulinism | 2 | 2017 | 414 | 0.180 |
Why?
|
Prevalence | 7 | 2022 | 14992 | 0.170 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2019 | 35 | 0.170 |
Why?
|
Cross-Sectional Studies | 9 | 2023 | 24031 | 0.170 |
Why?
|
Absorptiometry, Photon | 2 | 2019 | 1691 | 0.170 |
Why?
|
Serum | 2 | 2019 | 214 | 0.170 |
Why?
|
Methylamines | 2 | 2016 | 115 | 0.170 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 4515 | 0.170 |
Why?
|
Comorbidity | 5 | 2020 | 10247 | 0.160 |
Why?
|
Young Adult | 15 | 2021 | 55781 | 0.160 |
Why?
|
Research Subjects | 1 | 2020 | 236 | 0.160 |
Why?
|
Heart Diseases | 1 | 2011 | 2765 | 0.160 |
Why?
|
Anti-Mullerian Hormone | 1 | 2020 | 400 | 0.160 |
Why?
|
Hepatitis C | 1 | 2018 | 1565 | 0.150 |
Why?
|
Natriuretic Peptides | 1 | 2018 | 147 | 0.150 |
Why?
|
Tomography, X-Ray | 1 | 2016 | 60 | 0.150 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 789 | 0.150 |
Why?
|
Food Supply | 1 | 2022 | 495 | 0.140 |
Why?
|
Adolescent | 18 | 2021 | 84401 | 0.140 |
Why?
|
Angiography | 3 | 2016 | 1609 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 5 | 2020 | 2533 | 0.140 |
Why?
|
Smoking | 1 | 2013 | 8879 | 0.140 |
Why?
|
Reverse Transcriptase Inhibitors | 3 | 2022 | 613 | 0.140 |
Why?
|
Muscle Cells | 1 | 2016 | 195 | 0.140 |
Why?
|
Sodium | 2 | 2022 | 1594 | 0.140 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2127 | 0.130 |
Why?
|
Antiviral Agents | 1 | 2018 | 2895 | 0.130 |
Why?
|
Gender Identity | 1 | 2020 | 628 | 0.130 |
Why?
|
Aged | 20 | 2023 | 161486 | 0.130 |
Why?
|
Triglycerides | 3 | 2020 | 2519 | 0.130 |
Why?
|
Macrophage Activation | 1 | 2018 | 564 | 0.130 |
Why?
|
Pravastatin | 1 | 2017 | 395 | 0.130 |
Why?
|
Nutrition Policy | 1 | 2019 | 481 | 0.130 |
Why?
|
Diet Surveys | 1 | 2019 | 1170 | 0.130 |
Why?
|
Interleukin-10 | 1 | 2020 | 1205 | 0.120 |
Why?
|
Behavior Therapy | 1 | 2019 | 854 | 0.120 |
Why?
|
Blood Coagulation Disorders | 1 | 2016 | 335 | 0.120 |
Why?
|
Cholesterol, LDL | 4 | 2019 | 2318 | 0.120 |
Why?
|
Cholesterol, HDL | 2 | 2013 | 1797 | 0.120 |
Why?
|
International Cooperation | 1 | 2020 | 1414 | 0.110 |
Why?
|
Pericardium | 1 | 2018 | 663 | 0.110 |
Why?
|
Regression Analysis | 3 | 2013 | 6432 | 0.110 |
Why?
|
Adipose Tissue, White | 1 | 2016 | 351 | 0.110 |
Why?
|
Double-Blind Method | 7 | 2023 | 11883 | 0.110 |
Why?
|
Minority Groups | 1 | 2020 | 1130 | 0.110 |
Why?
|
Coronary Angiography | 4 | 2023 | 4430 | 0.110 |
Why?
|
Chemokine CXCL10 | 1 | 2013 | 304 | 0.110 |
Why?
|
Boston | 2 | 2019 | 9288 | 0.110 |
Why?
|
Menopause | 1 | 2020 | 1605 | 0.110 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2023 | 126 | 0.110 |
Why?
|
Anticholesteremic Agents | 2 | 2017 | 972 | 0.110 |
Why?
|
Sex Characteristics | 2 | 2023 | 2546 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 7 | 2019 | 19908 | 0.100 |
Why?
|
Cardiovascular System | 1 | 2018 | 793 | 0.100 |
Why?
|
Coronary Vessels | 3 | 2023 | 3016 | 0.100 |
Why?
|
Fenofibrate | 1 | 2011 | 93 | 0.100 |
Why?
|
Fibronectins | 1 | 2014 | 720 | 0.100 |
Why?
|
Niacin | 1 | 2011 | 115 | 0.100 |
Why?
|
Case-Control Studies | 7 | 2020 | 21591 | 0.100 |
Why?
|
Prospective Studies | 8 | 2022 | 51869 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1767 | 0.090 |
Why?
|
Iodide Peroxidase | 1 | 2012 | 289 | 0.090 |
Why?
|
Osteoporosis | 1 | 2019 | 1566 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 520 | 0.090 |
Why?
|
Hyperemia | 1 | 2011 | 209 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 2021 | 0.090 |
Why?
|
Pulsatile Flow | 1 | 2011 | 332 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3118 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6460 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1340 | 0.090 |
Why?
|
Manometry | 1 | 2011 | 420 | 0.090 |
Why?
|
Calorimetry, Indirect | 1 | 2009 | 180 | 0.080 |
Why?
|
Primary Prevention | 3 | 2023 | 1152 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2020 | 1831 | 0.080 |
Why?
|
Fibroblast Growth Factors | 1 | 2014 | 885 | 0.080 |
Why?
|
Lipodystrophy | 2 | 2006 | 144 | 0.080 |
Why?
|
Blood Pressure | 4 | 2018 | 8475 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2222 | 0.080 |
Why?
|
Blood Glucose | 3 | 2021 | 6217 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2017 | 1543 | 0.080 |
Why?
|
Patient Participation | 1 | 2017 | 1438 | 0.080 |
Why?
|
Stavudine | 1 | 2007 | 84 | 0.080 |
Why?
|
Extremities | 1 | 2012 | 857 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2012 | 1983 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2103 | 0.070 |
Why?
|
Adipogenesis | 2 | 2021 | 363 | 0.070 |
Why?
|
Hypertension | 2 | 2019 | 8262 | 0.070 |
Why?
|
Hyperlipidemias | 1 | 2011 | 785 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2018 | 61761 | 0.070 |
Why?
|
Mitochondria, Muscle | 1 | 2007 | 174 | 0.070 |
Why?
|
Liver | 2 | 2021 | 7494 | 0.070 |
Why?
|
Immunity | 1 | 2011 | 989 | 0.070 |
Why?
|
Cholesterol | 1 | 2014 | 2868 | 0.070 |
Why?
|
MicroRNAs | 1 | 2021 | 3715 | 0.070 |
Why?
|
Energy Metabolism | 3 | 2016 | 2934 | 0.070 |
Why?
|
Vitamin D | 1 | 2019 | 3177 | 0.060 |
Why?
|
Health Promotion | 1 | 2017 | 2136 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3621 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3511 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 13044 | 0.060 |
Why?
|
Back | 2 | 2016 | 65 | 0.060 |
Why?
|
Exercise Therapy | 1 | 2011 | 871 | 0.060 |
Why?
|
Aldosterone | 2 | 2022 | 856 | 0.060 |
Why?
|
Heart | 1 | 2017 | 4368 | 0.060 |
Why?
|
Chemokine CCL2 | 2 | 2017 | 626 | 0.060 |
Why?
|
Age Factors | 3 | 2020 | 18339 | 0.060 |
Why?
|
Diet, Sodium-Restricted | 2 | 2016 | 280 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2391 | 0.060 |
Why?
|
Body Size | 1 | 2006 | 455 | 0.060 |
Why?
|
Glucose Clamp Technique | 2 | 2018 | 265 | 0.060 |
Why?
|
United States | 5 | 2023 | 68403 | 0.060 |
Why?
|
Waist Circumference | 2 | 2019 | 908 | 0.060 |
Why?
|
Protease Inhibitors | 1 | 2006 | 799 | 0.050 |
Why?
|
Up-Regulation | 1 | 2012 | 4234 | 0.050 |
Why?
|
Nucleosides | 1 | 2022 | 140 | 0.050 |
Why?
|
Eating | 1 | 2009 | 1524 | 0.050 |
Why?
|
Lipids | 2 | 2018 | 3298 | 0.050 |
Why?
|
CCN Intercellular Signaling Proteins | 1 | 2021 | 25 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2021 | 41 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3083 | 0.050 |
Why?
|
Treatment Failure | 1 | 2018 | 2614 | 0.050 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2005 | 352 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5522 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5544 | 0.050 |
Why?
|
Risk Assessment | 4 | 2022 | 23185 | 0.050 |
Why?
|
Obesity | 2 | 2022 | 12419 | 0.050 |
Why?
|
CD4-CD8 Ratio | 1 | 2020 | 112 | 0.050 |
Why?
|
Statistical Distributions | 1 | 2020 | 66 | 0.050 |
Why?
|
Obesity, Abdominal | 2 | 2015 | 345 | 0.050 |
Why?
|
Receptors, Purinergic P2X5 | 1 | 2019 | 6 | 0.050 |
Why?
|
Ultrasonography | 2 | 2011 | 5891 | 0.050 |
Why?
|
Integrases | 1 | 2022 | 539 | 0.050 |
Why?
|
Amino Acid Transport Systems, Neutral | 1 | 2019 | 39 | 0.050 |
Why?
|
Reproduction | 2 | 2020 | 654 | 0.050 |
Why?
|
Massachusetts | 1 | 2013 | 8556 | 0.050 |
Why?
|
Oxygen Consumption | 1 | 2006 | 1895 | 0.050 |
Why?
|
Muscle, Skeletal | 2 | 2023 | 4951 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2012 | 6180 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2021 | 243 | 0.040 |
Why?
|
Dietary Fats | 1 | 2007 | 2038 | 0.040 |
Why?
|
Glucose | 2 | 2012 | 4315 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16272 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4257 | 0.040 |
Why?
|
North America | 1 | 2022 | 1208 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2023 | 718 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2021 | 595 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2009 | 12249 | 0.040 |
Why?
|
Cohort Studies | 5 | 2021 | 39918 | 0.040 |
Why?
|
HIV Protease Inhibitors | 1 | 2019 | 429 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 257 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2022 | 762 | 0.040 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2018 | 175 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2019 | 442 | 0.040 |
Why?
|
Transsexualism | 1 | 2020 | 171 | 0.040 |
Why?
|
Symporters | 1 | 2019 | 358 | 0.040 |
Why?
|
Hormones | 2 | 2014 | 868 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2020 | 1865 | 0.040 |
Why?
|
Galectin 3 | 1 | 2018 | 226 | 0.040 |
Why?
|
History, 21st Century | 1 | 2022 | 1530 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2021 | 1383 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2019 | 534 | 0.030 |
Why?
|
Malnutrition | 1 | 2022 | 604 | 0.030 |
Why?
|
Galectins | 1 | 2018 | 265 | 0.030 |
Why?
|
Gene Silencing | 1 | 2021 | 1565 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2020 | 3693 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7819 | 0.030 |
Why?
|
Body Fat Distribution | 1 | 2016 | 241 | 0.030 |
Why?
|
Adipocytes | 1 | 2021 | 1190 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1143 | 0.030 |
Why?
|
Down-Regulation | 1 | 2021 | 3024 | 0.030 |
Why?
|
Choline | 1 | 2015 | 482 | 0.030 |
Why?
|
Genotype | 1 | 2018 | 12902 | 0.030 |
Why?
|
Income | 1 | 2021 | 1829 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1589 | 0.030 |
Why?
|
Angiotensin II | 1 | 2015 | 892 | 0.030 |
Why?
|
Community Health Services | 1 | 2017 | 648 | 0.030 |
Why?
|
Self Report | 1 | 2022 | 3407 | 0.030 |
Why?
|
Spleen | 1 | 2017 | 2375 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2894 | 0.030 |
Why?
|
Placebos | 1 | 2016 | 1691 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2021 | 1576 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2016 | 1866 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4497 | 0.020 |
Why?
|
Drug Interactions | 1 | 2015 | 1448 | 0.020 |
Why?
|
Abdominal Fat | 1 | 2012 | 221 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1759 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2020 | 2016 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2023 | 4333 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2021 | 3042 | 0.020 |
Why?
|
Hypertrophy | 1 | 2012 | 566 | 0.020 |
Why?
|
American Heart Association | 1 | 2014 | 1032 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 11413 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3416 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3603 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1610 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3150 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2021 | 5041 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2359 | 0.020 |
Why?
|
Atrophy | 1 | 2012 | 1514 | 0.020 |
Why?
|
Body Constitution | 1 | 2007 | 276 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 3983 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2017 | 2284 | 0.020 |
Why?
|
Phosphocreatine | 1 | 2007 | 270 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14769 | 0.020 |
Why?
|
Phosphorus | 1 | 2007 | 334 | 0.020 |
Why?
|
Carotid Artery, Common | 1 | 2006 | 172 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5930 | 0.020 |
Why?
|
Hypertriglyceridemia | 1 | 2007 | 299 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2021 | 11507 | 0.020 |
Why?
|
Menstruation | 1 | 2005 | 289 | 0.020 |
Why?
|
Homeostasis | 1 | 2014 | 3330 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 7851 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2019 | 7921 | 0.010 |
Why?
|
Thorax | 1 | 2005 | 533 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11529 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1381 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9716 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2007 | 817 | 0.010 |
Why?
|
Protons | 1 | 2007 | 1126 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5237 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7840 | 0.010 |
Why?
|
Ovary | 1 | 2005 | 997 | 0.010 |
Why?
|
Anthropometry | 1 | 2005 | 1357 | 0.010 |
Why?
|
Transcription Factors | 1 | 2019 | 12080 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6728 | 0.010 |
Why?
|
Energy Intake | 1 | 2007 | 2148 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9379 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7254 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12180 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13157 | 0.010 |
Why?
|
Radiography | 1 | 2006 | 6935 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57656 | 0.010 |
Why?
|
Mice | 1 | 2021 | 80300 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 28737 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7670 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 34776 | 0.010 |
Why?
|
Bone Density | 1 | 2005 | 3433 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2005 | 13698 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168714 | 0.010 |
Why?
|
Neoplasms | 1 | 2017 | 20941 | 0.010 |
Why?
|